Jenavalve Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Interventionalists say it’s now time to make a dent in the complication rate, whether by strict protocols or smaller devices.

1. The 30-day composite primary safety endpoint of > 40.5% was achieved for Trilogy TAVI. 2. 8% of patients who underwent Trilogy TAVI had passed at the 1-year follow-up. Evidence Rating Level: 1 (Excellent) Study Rundown: Surgery remains the primary intervention for native aortic regurgitation, but high-risk patients lack optimal alternatives. Traditional transcatheter heart valves

Ann Robinson reviews the latest research Pregnancy and childbirth can be worrying times, and the news that adverse pregnancy outcomes are associated with an increased risk of dying younger will ramp up anxiety, but it also offers scope to shift the dial. This national Swedish cohort study of more than two million women found that any of five major adverse pregnancy outcomes (preterm delivery, small for gestational age, pre-eclampsia, other hypertensive disorders, and gestational diabetes) was associated with increased mortality risks that remained elevated up to 46 years later. The major cause...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Apr 6, 2024--

SUZHOU, China, Jan. 29, 2024 /PRNewswire/ -- Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese domestic player in the high-growth transcatheter